Prognostic markers in patients with COVID-19 requiring intensive care support

被引:0
|
作者
Maghrabi, Khalid A. [1 ]
AlQahtany, Fatmah S. [2 ]
AlOtair, Hadeel [3 ]
Maghrabi, Mohannad K. [4 ]
AlSaleh, Khalid [5 ]
Owaidah, Tarek [6 ,7 ,8 ]
机构
[1] King Faisal Specialist Hosp & Res Ctr, Res Ctr, Dept Crit Care Med, Riyadh, Saudi Arabia
[2] King Saud Univ, King Saud Univ Med City, Coll Med, Dept Pathol, Riyadh, Saudi Arabia
[3] King Saud Univ, King Saud Univ Med City, Dept Med, Riyadh, Saudi Arabia
[4] King Faisal Specialist Hosp & Res Ctr, Res Ctr, Dept Med, Riyadh, Saudi Arabia
[5] King Saud Univ, Coll Med, Dept Med, Riyadh, Saudi Arabia
[6] King Faisal Specialist Hosp & Res Ctr, Res Ctr, Dept Pathol, Lab Med, Riyadh, Saudi Arabia
[7] Alfaisal Univ, Riyadh, Saudi Arabia
[8] Alfaisal Univ, King Faisal Specialist Hosp, Ctr Excellence Thrombosis & Hemostasis, Haematol & Transfus Med cine, POB 3354, Riyadh 11211, Saudi Arabia
来源
JOURNAL OF TAIBAH UNIVERSITY MEDICAL SCIENCES | 2023年 / 18卷 / 05期
关键词
Coagulation; COVID-19; ICU; Markers; KSA; CORONAVIRUS DISEASE 2019; CLINICAL CHARACTERISTICS; THROMBOSIS; COAGULOPATHY; METAANALYSIS; COAGULATION; PNEUMONIA; MORTALITY; OBESITY;
D O I
10.1016/j.jtumed.2023.02.013
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: Several hematological and immunological markers, particularly neutrophil count, predict the severity of COVID-19. This study aimed at assessing hematological and coagulation parameters at different time points, to predict the complications or outcomes of patients with COVID-19 admitted to the intensive care unit (ICU).Methods: We conducted a prospective observational multicenter study in ICU departments. A total of 118 patients with COVID-19 admitted to the ICU were included. Clinical data and blood samples from routine hematology and coagulation tests were collected at admission, and on days 3, 7, and 14. The main outcome measures were high-flow-O2 requirement, thrombosis, and 30-day mortality.Results: The venous thromboembolism score increased from a mean of 5.10 +/- 2 on day 0 to 6.40 +/- 2.80 on day 14 (P = 0.0002). The disseminated intravascular coagu-lation (DIC) score significantly correlated with throm-bosis (P = 0.031). A total of 41.20% of patients in the ICU had a DIC score >4, and 11.40% had a score <4. Mortality was negatively associated with patients on high-flow O2, 9 patients (10.80%) (P = 0.040), and positively associated with patients receiving ventilation, 16 patients (27.50%) (P < 0.001). An increase in white blood cell count (subdistribution hazard ratio (SHR): 0.91; 95% CI: 0.80-1) and neutrophil count (SHR: 1; 95% CI: 1.01-1.05) was associated with greater disease severity and D-dimer level (SHR: 1.60; 95% CI: 1.10-2.5).Conclusion: The venous thromboembolism score was significantly higher for patients who died than those who recovered. Furthermore, mechanical ventilation was associated with high mortality, whereas the risk of thrombosis and ICU admission correlated with high D-dimer values and DIC scores. Therefore, D-dimer levels and DIC scores are prognostic markers that may predict disease severity in patients with COVID-19.
引用
收藏
页码:1089 / 1098
页数:10
相关论文
共 50 条
  • [31] Echocardiography for patients with COVID-19 in intensive care
    Powys-Lybbe, J.
    Aron, J.
    BJA EDUCATION, 2022, 22 (01) : 2 - 4
  • [32] The Relationship of Comorbidities with Intensive Care Unit Admission and Mortality in Patients with COVID-19
    Yildiz, Busra
    Erden, Seyfettin
    Oz, Ahmet
    Karabag, Turgut
    TURKISH JOURNAL OF ANAESTHESIOLOGY AND REANIMATION, 2022, 50 (03) : 187 - 193
  • [33] Evaluation of Hepcidin Level in COVID-19 Patients Admitted to the Intensive Care Unit
    Ciotti, Marco
    Nuccetelli, Marzia
    Pieri, Massimo
    Petrangeli, Carlo Maria
    Giovannelli, Alfredo
    Cosio, Terenzio
    Rosa, Luigi
    Valenti, Piera
    Leonardis, Francesca
    Legramante, Jacopo Maria
    Bernardini, Sergio
    Campione, Elena
    Minieri, Marilena
    DIAGNOSTICS, 2022, 12 (11)
  • [34] Favipiravir Experience in COVID-19 Patients at a Tertiary Center Intensive Care Unit
    Sevinc, Sultan Acar
    Cinar, Ayse Surhan
    Basi, Nermin Balta
    Metin, Seyhan
    Yucel, Tugba
    Islamoglu, Serkan
    Altinay, Mustafa
    Ozdemir, Haci Mustafa
    MEDICAL BULLETIN OF SISLI ETFAL HOSPITAL, 2022, 56 (02): : 189 - 195
  • [35] Respiratory supports of COVID-19 patients in intensive care unit: A systematic review
    Ouyang, Lichen
    Yu, Muqing
    Zhu, Yan
    Gong, Jie
    HELIYON, 2021, 7 (04)
  • [36] The Effects of Smoking in Patients in the Intensive Care Unit During the COVID-19 Pandemic
    Metin, Seyhan
    Basi, Nermin Balta
    Sevinc, Sultan Acar
    Salkaya, Aysel
    Coskun, Nurcan
    Turkoglu, Leyla Kilinc
    Cinar, Ayse Surhan
    Oba, Sibel
    Ozdemir, Haci Mustafa
    MEDICAL BULLETIN OF SISLI ETFAL HOSPITAL, 2023, 57 (04): : 520 - 525
  • [37] Intensive care therapy for COVID-19
    Becker, Andre P.
    Mang, Sebastian
    Rixecker, Torben
    Lepper, Philipp M.
    PNEUMOLOGIE, 2024, 78 (05): : 330 - 345
  • [38] Gender-Specific Differences in the Intensive Care Treatment of COVID-19 Patients
    Jirak, Peter
    Mirna, Moritz
    Van Almsick, Vincent
    Shomanova, Zornitsa
    Mahringer, Magdalena
    Lichtenauer, Michael
    Kopp, Kristen
    Topf, Albert
    Sieg, Franz
    Kraus, Johannes
    Gharibeh, Sarah X.
    Hoppe, Uta C.
    Fiedler, Lukas
    Larbig, Robert
    Pistulli, Rudin
    Motloch, Lukas J.
    Dieplinger, Anna-Maria
    JOURNAL OF PERSONALIZED MEDICINE, 2022, 12 (05):
  • [39] A Comparison of Methylprednisolone and Dexamethasone in Intensive Care Patients With COVID-19
    Ko, Justine J.
    Wu, Clay
    Mehta, Neha
    Wald-Dickler, Noah
    Yang, Wei
    Qiao, Renli
    JOURNAL OF INTENSIVE CARE MEDICINE, 2021, 36 (06) : 673 - 680
  • [40] THE PREDICTIVE ROLE OF BIOCHEMICAL MARKERS ON OUTCOMES OF SEVERE COVID-19 PATIENTS ADMITTED TO INTENSIVE CARE UNIT
    Mirjanic-Azaric, Bosa
    Pejic, Ivana
    Mijic, Smiljana
    Pejcic, Aleksandra
    Svraka, Anita Djurdjevic
    Svraka, Dragan
    Knezevic, Darija
    Milivojac, Tatjana
    Bogavac-Stanojevic, Natasa
    JOURNAL OF MEDICAL BIOCHEMISTRY, 2023, 42 (03) : 513 - 523